Article Text

PDF
Correspondence
Tumour necrosis factor-α is a foe for patients with acute myocardial infarction
  1. Kai-Hu Shi1,2,
  2. Hui Tao1,2,
  3. Jun-Xu Wu1,2
  1. 1 Department of Cardiothoracic Surgery, The Second Hospital of Anhui Medical University, Hefei, China
  2. 2 Cardiovascular Research Center, Anhui Medical University, Hefei, China
  1. Correspondence to Dr Kai-Hu Shi, Department of Cardiothoracic Surgery, The Second Hospital of Anhui Medical University, Furong Road, Anhui Province, Hefei 230601, China; ayskh3{at}hotmail.com

Statistics from Altmetric.com

To the Editor Tumour necrosis factor-α (TNF-α) has been implicated in the development of acute myocardial infarction. The mechanisms of TNF-α on endothelial function and platelet activation in patients with acute myocardial infarction are still unclear. A recent article by Padfield et al 1 demonstrated that TNF-α antagonism is unlikely to be a beneficial therapeutic strategy in patients with acute myocardial infarction. And plasma TNF-α concentrations increased in all patients following etanercept. This …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles